HIV & AIDS
Twice-yearly injection cuts HIV risk by 96%, but will cost cut access?
It could be a real breakthrough for people at risk for HIV infection: A shot given every six months that reduces their risk by a whopping 96%.
Sep 13, 2024
0
0
Hiv Infection
HIV & AIDS
Study: First sustained remission of HIV infection following a bone marrow transplant in absence of protective mutation
A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term remission of HIV infection ...
Sep 5, 2024
0
2
Genetics
Study finds potential link between DNA markers and aging process
Researchers at Weill Cornell Medicine and the epigenetics company TruDiagnostic have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material in our genes that act as highly accurate ...
Aug 19, 2024
0
43
Oncology & Cancer
Gen X and millennials at greater risk of 17 types of cancer compared to previous generations
A worrying new study by the American Cancer Society has revealed that generation X and millennials are at more risk of developing many types of cancer than their predecessors. This is in line with a growing body of evidence ...
Aug 11, 2024
0
6
Medications
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'
Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday.
Jul 24, 2024
1
5
Medications
New 'vaccine-like' HIV drug could cost just $40: Researchers
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
Jul 23, 2024
0
54
Medical research
Llama nanobodies: New therapy can neutralize a wide variety of HIV-1 strains
A research team at Georgia State University has developed tiny, potent molecules that are capable of targeting hidden strains of HIV. The source? Antibody genes from llama DNA.
Jul 17, 2024
0
41
Immunology
Study shows autoantibodies behind lifelong risk of viral infection
A new study, published in the Journal of Experimental Medicine, shows that about 2% of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral ...
Jul 17, 2024
0
55
Oncology & Cancer
Vaginal cancer incidence increasing globally
The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics and Gynaecology.
Jul 3, 2024
0
0
Medications
Pre-exposure prophylaxis for HIV is available—why are so many at-risk individuals ending up HIV positive?
In a far-reaching effort to understand the factors contributing to HIV transmission among sexual and gender minority (SGM) individuals and improve HIV prevention strategies, a team of scientists at the CUNY Graduate School ...
Jun 27, 2024
0
1
